Medicare Enrolled
Dr. Pinak Acharya, MD
Critical Care Medicine · Doylestown, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Acharya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Acharya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Acharya
Dr. Pinak Acharya is a critical care medicine specialist in Doylestown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Acharya performed 4,420 Medicare services across 3,607 unique beneficiaries.
Between the years covered by Open Payments, Dr. Acharya received a total of $15,402 from 47 pharmaceutical and/or device companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Acharya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in PA
$15,402 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,420
Medicare services
Top 2% in PA for critical care medicine
3,607
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~221 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,053 | $141 | $290 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
462 | $32 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
398 | $99 | $205 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
310 | $28 | $80 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
294 | $47 | $95 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
290 | $36 | $80 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
275 | $97 | $200 |
| Hemoglobin measurement A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
253 | $5 | $18 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
233 | $169 | $435 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
181 | $32 | $80 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
127 | $15 | $75 |
| New patient office visit, complex (60-74 min) | 104 | $167 | $420 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
41 | $29 | $50 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
39 | $14 | $45 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $120 | $345 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
37 | $52 | $110 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
34 | $142 | $300 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
33 | $5 | $250 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
33 | $77 | $150 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
29 | $15 | $30 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
26 | $47 | $280 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
19 | $72 | $86 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
19 | $32 | $48 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
16 | $12 | $250 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
16 | $32 | $48 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
14 | $283 | $400 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $106 | $360 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
11 | $7 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $98 | $225 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
11 | $65 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,402
Total received (2018-2024)
Avg $2,200/year across 7 years
Top 8% in PA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
486
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,788 (57.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,613 (42.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,674
2023
$1,424
2022
$8,251
2021
$1,092
2020
$444
2019
$1,204
2018
$1,313
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$252
GlaxoSmithKline, LLC.
$246
AstraZeneca Pharmaceuticals LP
$212
Electromed, Inc.
$157
GENZYME CORPORATION
$137
Insmed, Inc.
$129
SANOFI-AVENTIS U.S. LLC
$100
Regeneron Healthcare Solutions, Inc.
$96
PFIZER INC.
$74
Philips North America LLC
$60
Resmed Corp
$40
Novartis Pharmaceuticals Corporation
$34
United Therapeutics Corporation
$30
Astellas Pharma US Inc
$29
Axsome Therapeutics, Inc.
$24
CSL Behring
$22
La Jolla Pharmaceutical Company
$18
Mylan Specialty L.P.
$14
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$6,542
GlaxoSmithKline, LLC.
$1,631
Actelion Pharmaceuticals US, Inc.
$784
AstraZeneca Pharmaceuticals LP
$724
Insmed, Inc.
$632
Regeneron Healthcare Solutions, Inc.
$517
Boehringer Ingelheim Pharmaceuticals, Inc.
$501
Genentech USA, Inc.
$492
Novartis Pharmaceuticals Corporation
$376
PFIZER INC.
$277
GENZYME CORPORATION
$265
INTUITIVE SURGICAL, INC.
$252
United Therapeutics Corporation
$244
Sunovion Pharmaceuticals Inc.
$233
Electromed, Inc.
$214
Mylan Specialty L.P.
$211
JAZZ PHARMACEUTICALS INC.
$130
SANOFI-AVENTIS U.S. LLC
$121
Resmed Corp
$94
Boston Scientific Corporation
$93
Merck Sharp & Dohme Corporation
$85
Axsome Therapeutics, Inc.
$82
Philips Electronics North America Corporation
$63
Philips North America LLC
$60
Advanced Respiratory, Inc
$57
Janssen Pharmaceuticals, Inc
$55
Jazz Pharmaceuticals Inc.
$49
Merck Sharp & Dohme LLC
$48
Mallinckrodt Hospital Products Inc.
$47
Amgen Inc.
$45
Harmony Biosciences LLC
$42
Alexion Pharmaceuticals, Inc.
$42
ABBVIE INC.
$39
Circassia Pharmaceuticals Inc
$35
Shire North American Group Inc
$34
La Jolla Pharmaceutical Company
$33
Takeda Pharmaceuticals U.S.A., Inc.
$33
IDORSIA PHARMACEUTICALS US INC
$31
Astellas Pharma US Inc
$29
Inogen, Inc.
$26
Pulmonx Corporation
$24
EISAI INC.
$24
CSL Behring
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
Eisai Inc.
$16
Vapotherm Inc
$15
Medtronic, Inc.
$15
Top 3 companies account for 58.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADVAIR · AIRCURVE · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · AVYCAZ · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · CHARTIS CATHETER · CUVITRU · DUPIXENT · Da Vinci Surgical System · Dayvigo · ELIQUIS · Esbriet · FARXIGA · FASENRA · GIAPREZA · GLASSIA · General - Pulmonary · HawkOne · Hizentra · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · JANUVIA · LONHALA MAGNAIR · Lenvima · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Perforomist · Precision Flow · QUVIVIQ · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Stivarga · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Ultomiris · Utibron · WAKIX · XARELTO · XOLAIR · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for critical care medicine in PA.
Geographic Context
Critical care medicines within 10 mi
106
Per 100K population
16.4
County median income
$111,951
Nearest hospital
DOYLESTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Acharya is a clinical cardiology specialist, with above-average Medicare volume (top 2% in PA), with low-engagement industry engagement in the top 8% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Acharya experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Acharya performed 1,053 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Acharya receive payments from pharmaceutical companies?
Yes. Dr. Acharya received a total of $15,402 from 47 companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Acharya's costs compare to other critical care medicines in Doylestown?
Dr. Acharya's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Acharya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Doylestown
Browse critical care medicines in Doylestown ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in PA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in PA
Which PA critical care medicines receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology